Hilton Capital Management LLC Has $1.08 Million Stake in Teleflex Incorporated (NYSE:TFX)

Hilton Capital Management LLC increased its holdings in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 4.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,086 shares of the medical technology company’s stock after purchasing an additional 268 shares during the quarter. Hilton Capital Management LLC’s holdings in Teleflex were worth $1,083,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the company. Apollon Wealth Management LLC lifted its stake in Teleflex by 3.7% in the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock valued at $377,000 after acquiring an additional 55 shares during the last quarter. SRS Capital Advisors Inc. lifted its stake in Teleflex by 0.3% in the third quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock valued at $4,844,000 after acquiring an additional 60 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. lifted its stake in Teleflex by 4.5% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock valued at $375,000 after acquiring an additional 66 shares during the last quarter. HighTower Advisors LLC lifted its stake in Teleflex by 1.7% in the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock valued at $986,000 after acquiring an additional 66 shares during the last quarter. Finally, Huntington National Bank lifted its stake in Teleflex by 32.5% in the third quarter. Huntington National Bank now owns 310 shares of the medical technology company’s stock valued at $77,000 after acquiring an additional 76 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have commented on TFX. Morgan Stanley cut their price target on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating for the company in a research note on Wednesday, March 5th. Truist Financial dropped their price objective on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a research report on Monday, March 3rd. Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 27th. Raymond James lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. Finally, StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $182.63.

Check Out Our Latest Stock Analysis on Teleflex

Teleflex Price Performance

NYSE:TFX opened at $137.79 on Friday. Teleflex Incorporated has a 52 week low of $128.55 and a 52 week high of $249.90. The firm has a market cap of $6.39 billion, a price-to-earnings ratio of 27.39, a P/E/G ratio of 1.73 and a beta of 1.21. The firm’s 50-day simple moving average is $166.99 and its 200 day simple moving average is $197.99. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.

Teleflex (NYSE:TFXGet Free Report) last released its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. As a group, sell-side analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, March 7th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.99%. The ex-dividend date is Friday, March 7th. Teleflex’s payout ratio is presently 95.77%.

About Teleflex

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Further Reading

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFXFree Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.